l-carnitine supplement source food molecule | Stock Image L-Carnitine 3000 Liquid

A placebo-controlled RCT in HVs investigating the safety, tolerability and PK (Pharmacokinetic) of TD139, a galectin-3 inhibitor, followed by an expansion cohort treating subjects with Idiopathic Pulmonary Fibrosis (IPF)

Studies have shown that vitamin D can inhibit TGF--Smad signaling pathway (156, 158160) through the specific process of 1,25(OH) 2 D 3 binding complex with VDR, which directly interacts with SMAD3 to reduce the binding of SMAD3 to DNA, and ultimately inhibit TGF--Smad signal transduction (161, 162)

Heparan sulfate glycosaminoglycan requirement for Met binding and signaling

Neurochem Res 20:931937

Anyone presenting the combination as clinically proven is going beyond the evidence